文献速递血栓与止血

住院COVID-19患者症状性静脉血栓栓塞的临床特征与危险因素:多中心回顾性研究

Clinical characteristics and risk factors for symptomatic venous thromboembolism in hospitalized COVID-19 patients: A multicenter retrospective study.
PubMed 文献 · J Thromb Haemost · 2021-02-24

该多中心回顾性研究纳入中国16中心2020年1月1日至3月31日确诊COVID-19的2779例患者,比较其与23434例非COVID-19内科住院患者的症状性VTE风险。重度和非重度COVID-19患者的症状性VTE比值比分别为5.94和2.79;104例VTE与208例非VTE对照分析显示,D-二聚体增量≥1.5倍与VTE关联最强,基于三项凝血变量的新模型预测症状性VTE的AUC为0.865。

要点

  • 住院COVID-19患者症状性VTE风险显著高于非COVID-19内科住院患者。
  • D-二聚体增量≥1.5倍是与VTE关联最强的独立因素(OR 14.18)。
  • 三项凝血变量新模型对症状性VTE预测AUC为0.865,敏感度0.930。

核心结论

  • 住院COVID-19患者存在超额VTE风险,基于凝血指标的新模型有助于早期识别VTE高危患者。

研究设计与样本

  • 多中心回顾性研究,纳入中国16中心2020年1月1日至3月31日确诊的2779例COVID-19患者,并与23434例非COVID-19内科住院患者比较。
  • VTE分析中比较104例VTE病例与208例非VTE病例。

主要发现

  • 重度住院COVID-19患者发生症状性VTE的OR为5.94(95%CI 3.91-10.09),非重度为2.79(95%CI 1.43-5.60)。
  • 肺栓塞病例院内死亡OR为6.74(95%CI 2.18-20.81)。
  • VTE发生中位时间为症状出现后21天(IQR 13.25-31)。
  • VTE独立因素包括高龄、癌症、症状至入院间隔较长、入院时纤维蛋白原较低和D-二聚体较高,以及D-二聚体增量≥1.5倍(OR 14.18,95%CI 6.25-32.18,p=2.23×10^-10)。

关键数值与推荐

  • 基于入院时纤维蛋白原、D-二聚体及D-二聚体增量≥1.5倍三项凝血变量构建的新模型预测症状性VTE:AUC 0.865(95%CI 0.822-0.907),敏感度0.930,特异度0.710。

临床怎么用

  • 对住院COVID-19患者应关注症状性VTE风险,可结合入院凝血指标及D-二聚体动态变化进行早期风险分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: High incidence of asymptomatic venous thromboembolism (VTE) has been observed in severe COVID-19 patients, but the characteristics of symptomatic VTE in general COVID-19 patients have not been described. OBJECTIVES: To comprehensively explore the prevalence and reliable risk prediction for VTE in COVID-19 patients. METHODS/RESULTS: This retrospective study enrolled all COVID-19 patients with a subsequent VTE in 16 centers in China from January 1 to March 31, 2020. A total of 2779 patients were confirmed with COVID-19. In comparison to 23,434 non-COVID-19 medical inpatients, the odds ratios (ORs) for developing symptomatic VTE in severe and non-severe hospitalized COVID-19 patients were 5.94 (95% confidence interval [CI] 3.91-10.09) and 2.79 (95% CI 1.43-5.60), respectively. When 104 VTE cases and 208 non-VTE cases were compared, pulmonary embolism cases had a higher rate for in-hospital death (OR 6.74, 95% CI 2.18-20.81). VTE developed at a median of 21 days (interquartile range 13.25-31) since onset. Independent factors for VTE were advancing age, cancer, longer interval from symptom onset to admission, lower fibrinogen and higher D-dimer on admission, and D-dimer increment (DI) ≥1.5-fold; of these, DI ≥1.5-fold had the most significant association (OR 14.18, 95% CI 6.25-32.18, p = 2.23 × 10-10 ). A novel model consisting of three simple coagulation variables (fibrinogen and D-dimer levels on admission, and DI ≥1.5-fold) showed good prediction for symptomatic VTE (area under the curve 0.865, 95% CI 0.822-0.907, sensitivity 0.930, specificity 0.710). CONCLUSIONS: There is an excess risk of VTE in hospitalized COVID-19 patients. This novel model can aid early identification of patients who are at high risk for VTE.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Li JY, Wang HF, Yin P, et al. Clinical characteristics and risk factors for symptomatic venous thromboembolism in hospitalized COVID-19 patients: A multicenter retrospective study. J Thromb Haemost. 2021. PMID: 33534149. doi:10.1111/jth.15261

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。